Blepharospasm clinical trials
The registry lists 43 studies for Blepharospasm across more than 10 countries. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-24.
Status
- Completed
- 29
- Status unknown
- 7
- Terminated
- 5
- Not yet recruiting
- 1
- Withdrawn
- 1
Phase
- Phase 2
- 12
- Phase 3
- 8
- Phase 4
- 5
- Early Phase 1
- 2
- Phase 1
- 2
Where
- United States
- 17
- China
- 5
- Korea, Republic of
- 5
- Germany
- 4
- Canada
- 4
- France
- 3
Who runs them
National Institute of Neurological Disorders and Stroke (NINDS) (7) · Merz Pharmaceuticals GmbH (4) · Allergan (4) · University Hospital, Grenoble (2) · Medy-Tox (2) · Hugel (2) · Ipsen (2) · Second Affiliated Hospital, School of Medicine, Zhejiang University (2)
Studies
Recruiting first, then most recently updated. Showing 43 of 43 — search for more.
- DaxibotulinumtoxinA for BlepharospasmNot yet recruitingNCT07489430Phase 21 country
- Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal DystoniaCompletedNCT03938363Not applicable1 country
- Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With BlepharospasmCompletedNCT05027997Phase 21 country
- Effect of Topical Botulinum Toxin Eyedrop on Palpebral FissureTerminatedNCT06080438Phase 41 country
- Safety and Efficacy of Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops Treatment for Dry Eye Diseases Post Refractive Surgery and Associated With BlepharospasmStatus unknownNCT05738629Phase 1/21 country
- Wumeiwan Jiawei Fang Use in Patients With BlepharospasmStatus unknownNCT05618470Phase 2/31 country
- Blepharospasm Patient Survey for Patients With BlepharospasmCompletedNCT016860611 country
- The Role of the Upper Colliculus in the Idiopathic BlepharospasmCompletedNCT03903341Not applicable1 country
- Botulinum Toxin Relieves Anxiety, Depression and Sleep Disorderes in Patients With BlepharospasmStatus unknownNCT04939909Early Phase 11 country
- Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum ToxinCompletedNCT051032021 country
- An RCT of a Patient-initiated Treatment Service for BEB and HFSCompletedNCT02577224Not applicable1 country
- Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in BlepharospasmCompletedNCT04423341Phase 2/31 country
- Influence of Gaze Shift and Emotions on Symptoms of BlepharospasmWithdrawnNCT017597451 country
- A Comparative Study of GPI's DBS and Pallidotomy in the Treatment of Meige SyndromeStatus unknownNCT046188871 country
- Post Marketing Surveillance Study of DysportCompletedNCT002104313 countries
- Brain Changes in BlepharospasmTerminatedNCT004873831 country
- Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential BlepharospasmCompletedNCT00234507Phase 21 country
- Safety and Efficacy of NABOTA in Treatment of Essential BlepharospasmCompletedNCT02947815Phase 2/31 country
- Blepharospasm ToolsCompletedNCT027803364 countries
- Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid SpasmCompletedNCT03508882Phase 4
- Photic Blink Reflex in People With Blepharospasm and Increased BlinkingTerminatedNCT032630001 country
- HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse ReactionsStatus unknownNCT03184597Not applicable1 country
- The Objective of This Study is to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm.CompletedNCT03641950Phase 41 country
- Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the EyelidCompletedNCT01896895Phase 33 countries
- A Mechanical Device for BlepharospasmCompletedNCT03269123Not applicable
- Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential BlepharospasmCompletedNCT03216473Phase 3
- Brain Stimulation to Treat Blepharospasm or Meige SyndromeCompletedNCT00411255Phase 21 country
- Brain Changes in BlepharospasmCompletedNCT005007991 country
- Acetyl Hexapeptide-8 for BlepharospasmTerminatedNCT01750346Phase 21 country
- Two Different Surgical Methods of BlepharospasmStatus unknownNCT02765113Early Phase 1
- A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and BlepharospasmCompletedNCT022459582 countries
- Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United StatesCompletedNCT012872471 country
- MDs on Botox Utility (MOBILITY)CompletedNCT005359381 country
- A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and BlepharospasmCompletedNCT018147742 countries
- Comparison of Two Botulinum Type A Products in the Treatment of BlepharospasmCompletedNCT00761592Phase 41 country
- IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of BlepharospasmCompletedNCT00406367Phase 32 countries
- Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential BlepharospasmCompletedNCT01791881Phase 31 country
- A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of BlepharospasmCompletedNCT00942851Phase 1/21 country
- Efficacy and Safety Study of Meditoxin® to Treat Essential BlepharospasmCompletedNCT01259557Phase 41 country
- Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial SpasmStatus unknownNCT01546805Not applicable1 country
- Blepharospasm Short IntervalTerminatedNCT00507637Phase 21 country
- Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential BlepharospasmCompletedNCT00682760Phase 31 country
- Mexiletine for the Treatment of Focal DystoniaCompletedNCT00001784Phase 21 country